COVID-19 Business Intelligence and Analysis for Clinical Laboratories, Pathology Groups and Hospital Administration
Reliable COVID-19 Business Intelligence and analysis for clinical laboratories, pathology groups and Laboratory Diagnostics.
It remains unclear if this pause will have an effect on people’s perception of the safety of the vaccine and if it will impact vaccination rates.
What clinical laboratory leaders can expect to find.
Three new recommendations for respirator supply management.
Streamlining authorizations will allow growth of asymptomatic testing as part of school, workplace, community, and other COVID-19 testing programs.
EUA revocation indicates that SARS-CoV-2 mutations are beginning to impact COVID-19 treatment efficacies.
Johnson and Johnson COVID-19 vaccine suspended as rare blood clotting disorder appears to be associated with the vaccine.
It remains unclear if this pause will have an effect on people’s perception of the safety of the vaccine and if it will impact vaccination rates.
What clinical laboratory leaders can expect to find.
Three new recommendations for respirator supply management.
Streamlining authorizations will allow growth of asymptomatic testing as part of school, workplace, community, and other COVID-19 testing programs.
EUA revocation indicates that SARS-CoV-2 mutations are beginning to impact COVID-19 treatment efficacies.
Johnson and Johnson COVID-19 vaccine suspended as rare blood clotting disorder appears to be associated with the vaccine.
